Published by Josh White on 30th June 2026
(Sharecast News) - Abivax shares surged on Tuesday after the French biotech released additional late-stage trial data that eased investor concerns over the safety of its lead ulcerative colitis treatment, obefazimod, while also highlighting further efficacy in difficult-to-treat patients.
URL: http://www.digitallook.com/dl/news/story/36040093/...